Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study

Klaus F. Rabe, Tito Atienza, Pál Magyar, +3

The Lancet

AsthmaAllergyMedicineDouble-blind StudyPulmonary Pharmacology +6

Effect of airway opening on production of exhaled particles

Ann‐Charlotte Almstrand, Björn Bake, Evert Ljungström, +4

Journal of Applied Physiology

AsthmaLung DepositionExhaled ParticlesAirborne ParticlesPhysiology +12

A pharmacoscintigraphic evaluation of oral budesonide given as controlled‐release (Entocort) capsules

Staffan Edsbäcker, Bengt Bengtsson, Per Larsson, +4

Alimentary Pharmacology & Therapeutics

Assessment of the relative systemic potency of inhaled fluticasone and budesonide

Martin Boorsma, Norma Andersson, Per Larsson, +1

European Respiratory Journal

AsthmaCortisol AnalysisRespiratory ToxicologyMedicineRelative Systemic Potency +10

Exhaled Endogenous Particles Contain Lung Proteins

Anna Bredberg, Johan Gobom, Ann‐Charlotte Almstrand, +4

Clinical Chemistry

Surfactant protein A and albumin in particles in exhaled air

Per Larsson, Ekaterina Mirgorodskaya, Lena Samuelsson, +4

Respiratory Medicine

Pulmonary SurfactantLung DepositionBiochemistrySurfactantsPulmonary Alveolar Proteinosis +4

TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls

Ann‐Charlotte Almstrand, Mats Josefson, Anna Bredberg, +4

European Respiratory Journal

AsthmaEngineeringInflammatory Lung DiseaseLung InflammationAir Quality +20

Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics

Johan Rosenborg, Thomas Bengtsson, Per Larsson, +3

European Journal of Clinical Pharmacology

AsthmaInhaled FormoterolAllergyHealthy SubjectsMedicine +4

Effects of breath holding at low and high lung volumes on amount of exhaled particles

Helene Holmgren, Emilie Gerth, Evert Ljungström, +4

Respiratory Physiology & Neurobiology

AsthmaHigh Lung VolumesExhaled ParticlesLung DepositionPulmonary Circulation +5

Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study

Mona Lärstad, Ann‐Charlotte Almstrand, Per Larsson, +5

PLoS ONE